ARCHIVES

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Conversation With The Cancer Letter: What $34,000 Per Patient Buys In Lung-MAP

June 20, 2014

NCI-Approved CTEP Trials For the Month of October

October 26, 2012

In Brief: Moertel To Deliver Karnofsky Lecture; Hopkins, Cold Spring Harbor Receive Bristol-Myers Awards

April 25, 1986

In Brief: Children’s Hospital Of Boston Names Pizzo Physician-In-chief; Lynch Wins Bristol Award

March 22, 1996

Call to Shift Two-Thirds Of Funds a “Rubber Number,” Bailar Says

June 6, 1997

How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval

September 30, 2011